市场调查报告书
商品编码
1500516
润喉糖市场:按成分类型、类型、应用、分销管道、应用分类 - 全球预测 2024-2030Throat Lozenges Market by Ingredient Type (Menthol Throat Lozenges, Non-Menthol Throat Lozenges), Type (Compressed Lozenges, Hard Candy Lozenges, Soft Lozenges), Usage, Distribution Channel, Application - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年润喉糖市场规模为40.5亿美元,预计2024年将达42.4亿美元,2030年将达56.6亿美元,复合年增长率为4.91%。
润喉糖是一种小锭剂,可在口腔中缓慢溶解,通常用于暂时缓解轻度喉咙痛和口腔发炎。这些含片含有薄荷醇、尤加利油、蜂蜜和各种草药萃取物,具有缓解感冒、流感和过敏症状、增加唾液分泌以缓解喉咙干燥等重要功效,甚至还具有抗菌特性,可以减少细菌的存在。 。由于多种因素,包括感冒和流感等呼吸道感染疾病的增加,以及空气污染和过敏原增加导致的喉咙不适,对润喉糖的需求正在稳步增加。感冒药的增加、流感等呼吸道感染疾病、空气污染和过敏都会导致喉咙痛。然而,市场面临替代疗法、与产品开发和商业化相关的严格法规、潜在副作用以及需求季节性波动等挑战。儘管存在这些障碍,但未来的前景包括开拓创新产品以满足不断增长的消费者需求、扩展到新兴市场、透过电子商务管道成长以及促进喉咙健康的教育健康宣传活动。
主要市场统计 | |
---|---|
基准年[2023] | 40.5亿美元 |
预测年份 [2024] | 42.4亿美元 |
预测年份 [2030] | 56.6亿美元 |
复合年增长率(%) | 4.91% |
区域洞察
在美洲,润喉糖市场正在稳定成长,由于呼吸道疾病、感冒和流感的盛行率日益增加,人们开始采用锭剂。此外,美国主要製药公司的存在带动了润喉糖的技术创新。此外,人们对非处方治疗的认识不断增强,这也促进了该地区润喉糖的销售。尤其是在欧洲国家,在感冒发烧多发的冬季,润喉糖的使用率很高。欧洲因其既定的药物开发和商业化监管标准而吸引製造商。在中东和非洲,由于都市化的加速和医疗保健机会的改善,润喉糖市场正在稳步成长。在亚太地区,润喉糖市场正在经历强劲成长。这是因为人口众多,喉咙感染疾病和呼吸道疾病的发生率较高,因此需要有效的治疗。
FPNV定位矩阵
FPNV 定位矩阵对于评估喉咙含片市场供应商的市场定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对润喉糖市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对喉咙含片市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[189 Pages Report] The Throat Lozenges Market size was estimated at USD 4.05 billion in 2023 and expected to reach USD 4.24 billion in 2024, at a CAGR 4.91% to reach USD 5.66 billion by 2030.
Throat lozenges are small, medicated tablets designed to dissolve slowly in the mouth, which are commonly used to provide temporary relief for minor sore throat and mouth irritation. These lozenges, which often contain ingredients including menthol, eucalyptus oil, honey, and various herbal extracts, serve key functions, including symptom relief from colds, flu, allergies, increasing saliva production for dry throats, and even possessing antiseptic properties to reduce bacterial presence. The need for throat lozenges has been rising steadily due to multiple factors, which include increased respiratory infections such as colds and flu, exacerbated by growing air pollution and allergens, leading to throat discomfort. Their convenience and easy over-the-counter availability make them a popular choice for quick relief. However, the market faces challenges from alternative remedies, stringent regulations associated with product development and commercialization, possible side effects, and seasonal demand fluctuations. Despite these hurdles, future opportunities abound, including innovative product development to meet the increasing consumer need, expansion into emerging global markets, growth through eCommerce channels, and educational health campaigns promoting throat health.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 4.05 billion |
Estimated Year [2024] | USD 4.24 billion |
Forecast Year [2030] | USD 5.66 billion |
CAGR (%) | 4.91% |
Regional Insights
In the Americas, the throat lozenges market is growing steadily, with the adoption of this tablet owing to the increasing prevalence of respiratory issues, the common cold, and the flu. Moreover, the presence of major pharmaceutical companies in the United States leads to innovations in throat lozenges. Additionally, there is a rising awareness about over-the-counter treatments, which is helping to drive sales of throat lozenges in the region. European countries, in particular, have a high adoption of throat lozenges, especially during the winter months when colds and fevers are more common. Well-established regulatory standards for the development and commercialization of pharmaceutical products in Europe attract manufacturers. In the Middle East and Africa, the throat lozenges market is growing steadily, with increasing urbanization and better healthcare access. Asia-Pacific is experiencing robust growth in the throat lozenges market. This is driven by a large population and a need for effective treatment for high incidence of throat infections and respiratory ailments.
Market Insights
The market dynamics represent an ever-changing landscape of the Throat Lozenges Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Throat Lozenges Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Throat Lozenges Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Sirio Pharma Ventures into Consumer Health Market with Innovative Herbal Gummies
Sirio Pharma expanded its consumer health market footprint following its recent softgel launch by introducing a series of herbal gummies targeting trending health categories. The range includes three vegan, low-to-no sugar gummies intended to address key health concerns, including cough and cold, oral care, and urinary tract infections (UTI). The 'cough and cold' gummy, with its blend of citrus extract, eucalyptus, and acacia honey, aims to enhance the conventional throat lozenges category by providing improved texture and taste. [Published On: 2023-10-06]
Launch of Beekeeper's Naturals Kid's Propolis Throat Soothing Lollipops
Beekeeper's Naturals expanded its range of child-friendly supplements with the introduction of Kid's Propolis Throat Soothing Lollipops following its recent launch at Walmart. Formulated in collaboration with doctors and rigorously tested by third-party labs to ensure they are pesticide-free, these lollipops blend propolis, vitamin D, zinc, wildflower honey, and other clean ingredients to soothe sore throats and bolster immune health. [Published On: 2023-08-22]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Throat Lozenges Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Throat Lozenges Market, highlighting leading vendors and their innovative profiles. These include Bausch Health Companies Inc., Bliss GVS Pharma Ltd, Catalent, Inc., Cipla Limited, Dabur Ltd, Doetsch Grether AG, Ernest Jackson Ltd., Gepach International, GSK PLC, Island Abbey Foods Ltd., J. B. Chemicals & Pharmaceuticals Limited, Mondelez International, Inc., Pfizer Inc., Piramal Group, Prestige Consumer Healthcare Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Ricola AG, Thornton & Ross Ltd, and Traditional Medicinals & WorldPantry.com LLC.
Market Segmentation & Coverage